CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+0.51%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.9B
AUM Growth
+$1.9B
(+8.5%)
Cap. Flow
+$161M
Cap. Flow
% of AUM
8.49%
Top 10 Holdings %
Top 10 Hldgs %
63.78%
Holding
40
New
10
Increased
11
Reduced
7
Closed
5
Top Buys
| 1 |
HCA Healthcare
HCA
|
$90.4M |
| 2 |
Bausch Health
BHC
|
$69.9M |
| 3 |
Cigna
CI
|
$42.4M |
| 4 |
OraSure Technologies
OSUR
|
$33.5M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$30.4M |
Top Sells
| 1 |
GSK
GSK
|
$96M |
| 2 |
Ascendis Pharma
ASND
|
$51.8M |
| 3 |
Glaukos
GKOS
|
$28M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$21.8M |
| 5 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
$17.9M |
Sector Composition
| 1 | Healthcare | 82.31% |
| 2 | Technology | 11.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHNG
1
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $218M | 11.48% | 15,000,000 -900,000 | -6% | -$13.1M |
|
2
Viatris
VTRS
$12.3B
| $178M | 9.39% | 12,000,000 +1,000,000 | +9% | +$14.8M |
|
|
ALXN
3
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $149M | 7.85% | 1,300,000 -100,000 | -7% | -$11.4M |
|
4
Perrigo
PRGO
$3.27B
| $131M | 6.9% | 2,850,000 +600,000 | +27% | +$27.5M |
|
5
Universal Health Services
UHS
$11.6B
| $123M | 6.49% | 1,150,000 +150,000 | +15% | +$16.1M |
|
6
Alkermes
ALKS
$4.78B
| $120M | 6.34% | 7,250,000 | – | – |
|
|
7
HCA Healthcare
HCA
$94.5B
| $90.4M | 4.77% | +725,000 | New | +$90.4M |
|
|
8
Bausch Health
BHC
$2.74B
| $69.9M | 3.69% | +4,500,000 | New | +$69.9M |
|
9
Ironwood Pharmaceuticals
IRWD
$214M
| $65.2M | 3.44% | 7,250,000 +750,000 | +12% | +$6.75M |
|
10
Myriad Genetics
MYGN
$593M
| $65.2M | 3.44% | 5,000,000 +1,000,000 | +25% | +$13M |
|
11
Sarepta Therapeutics
SRPT
$1.78B
| $59.7M | 3.15% | 425,000 +25,000 | +6% | +$3.51M |
|
|
BLUE
12
DELISTED
bluebird bio
BLUE
| $59.3M | 3.13% | 1,100,000 -175,000 | -14% | -$9.44M |
|
|
13
Cigna
CI
$80.3B
| $42.4M | 2.23% | +250,000 | New | +$42.4M |
|
14
Collegium Pharmaceutical
COLL
$1.22B
| $41.6M | 2.2% | 2,000,000 | – | – |
|
15
Nektar Therapeutics
NKTR
$568M
| $41.5M | 2.19% | 2,500,000 -500,000 | -17% | -$8.3M |
|
|
AMAG
16
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $41.3M | 2.18% | 4,390,000 | – | – |
|
17
Teva Pharmaceuticals
TEVA
$21.1B
| $40.5M | 2.14% | 4,500,000 +2,500,000 | +125% | +$22.5M |
|
18
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $40.3M | 2.13% | 2,200,000 | – | – |
|
19
Brookdale Senior Living
BKD
$1.83B
| $38.1M | 2.01% | 15,000,000 | – | – |
|
|
20
OraSure Technologies
OSUR
$242M
| $33.5M | 1.77% | +2,750,000 | New | +$33.5M |
|
|
21
BioMarin Pharmaceuticals
BMRN
$11.2B
| $30.4M | 1.61% | +400,000 | New | +$30.4M |
|
22
Puma Biotechnology
PBYI
$254M
| $25.8M | 1.36% | 2,555,000 +155,000 | +6% | +$1.56M |
|
23
Tenet Healthcare
THC
$16.3B
| $24.5M | 1.29% | +1,000,000 | New | +$24.5M |
|
|
RDUS
24
DELISTED
Radius Health, Inc.
RDUS
| $23.5M | 1.24% | 2,075,000 +1,700,000 | +453% | +$19.3M |
|
|
TECX
25
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $23.4M | 1.24% | 1,800,000 +450,000 | +33% | +$5.86M |
|